Christopher Dean
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Peptidase Inhibition and Analysis
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 44
- Radiopharmaceutical Chemistry and Applications 16
- Oncology 28
- HER2/EGFR in Cancer Research 20
- Co-authors
- Helmout Modjtahedi (13 shared papers)S. A. Eccles (11 shared papers)G. Box (7 shared papers)Jennifer A. Leeds (1 shared paper)Steve Hobbs (6 shared papers)M. Rufus Crompton (2 shared papers)Martin Pagé (2 shared papers)Michael J. Tilby (2 shared papers)
- Journals
- British Journal of Cancer (8 papers)International Journal of Cancer (6 papers)Clinical Oncology (3 papers)International Journal of Oncology (3 papers)Journal of Immunological Methods (3 papers)
- Partner nations
- United KingdomUnited StatesMalta
In The Last Decade
Christopher Dean
74 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 104
- Radiology, Nuclear Medicine and Imaging 579
- Oncology 587
- Radiation 127
- Immunology 275
- Biotechnology 112
Countries citing papers authored by Christopher Dean
This map shows the geographic impact of Christopher Dean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Dean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Dean more than expected).
Fields of papers citing papers by Christopher Dean
This network shows the impact of papers produced by Christopher Dean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Dean. The network helps show where Christopher Dean may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Dean, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 119 | |
| 2 | 1996 | 97 | |
| 3 | 1996 | 82 | |
| 4 | 2006 | 67 | |
| 5 | 1983 | 59 | |
| 6 | 2011 | 58 | |
| 7 | 1993 | 58 | |
| 8 | Regression of established breast carcinoma xenografts with antibody-directed enzyme prodrug therapy against c-erbB2 p185. | 1994 | 56 |
| 9 | 2003 | 53 | |
| 10 | Differentiation or immune destruction: two pathways for therapy of squamous cell carcinomas with antibodies to the epidermal growth factor receptor. | 1994 | 53 |
| 11 | 1991 | 50 | |
| 12 | Immunological detection of DNA damage caused by melphalan using monoclonal antibodies. | 1987 | 44 |
| 13 | Vaccination with syngeneic monoclonal anti-idiotype protects against a tumour challenge. | 1987 | 44 |
| 14 | 1998 | 42 | |
| 15 | 2021 | 39 | |
| 16 | 2013 | 35 | |
| 17 | 2005 | 35 | |
| 18 | 1994 | 29 | |
| 19 | Monoclonal antibodies to rat sarcomata. I. Immunization procedures and source of lymphoid cells for hybridoma production. | 1982 | 29 |
| 20 | 2010 | 28 |
About Christopher Dean
Christopher Dean is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Molecular Biology, Immunology and Radiation, having authored 79 papers that have together received 1.6k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (44 papers), HER2/EGFR in Cancer Research (20 papers), Radiopharmaceutical Chemistry and Applications (16 papers), Glycosylation and Glycoproteins Research (13 papers), T-cell and B-cell Immunology (6 papers), Protein purification and stability (5 papers), Toxin Mechanisms and Immunotoxins (5 papers) and Advanced Radiotherapy Techniques (5 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (579 citations), Oncology (587 citations), Radiation (127 citations), Immunology (275 citations) and Biotechnology (112 citations). Christopher Dean has collaborated with scholars based in United Kingdom, United States and Malta. Frequent co-authors include Helmout Modjtahedi, S. A. Eccles, G. Box, Jennifer A. Leeds, Steve Hobbs, M. Rufus Crompton, Martin Pagé, Michael J. Tilby, Niall MacDougall and R. Muirhead. Their work appears in journals such as British Journal of Cancer, International Journal of Cancer, Clinical Oncology, International Journal of Oncology and Journal of Immunological Methods.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.